Getting your global, small molecule CMC regulatory strategy right from the start

Webinar On Demand

Drug development is dynamic and engages CMC regulatory input at each step. It’s common to focus on the high-level, current tasks, without thinking more holistically about the CMC regulatory process and your molecule’s lifecycle. With a high-level focus, important steps and regulatory requirements are often missed, which can cause lengthy delays or additional costs to your project. As a result, it’s important to proactively plan and develop CMC regulatory strategies early on in your development process.

Download this webinar to hear industry expert, Betty Thompson, discuss:

  • Navigating a variety of regulatory CMC issues in product development to ensure market application readiness
  • Key considerations for product development to ensure global CMC requirements are met for clinical trial and marketing applications
  • Regional specific CMC data to support clinical trials for key countries: US, EU, UK, Australia, Canada and China